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either proapoptotic or antiapoptotic effects, depending on
the cell type, circumstances, or both. The responses and
roles of TGF-β1 in a variety of in vivo and in vitro condi-
tions have been reported.14-18 TGF-β1 could contribute
to the development of hypertension or vascular hypertro-
phy in spontaneous hypertensive rats.19 It has also been
reported that TGF-β1 further potentiates the induction of
apoptosis in endothelial cells (ECs) in serum-free media.14
Furthermore, TGF-β1 can prevent apoptosis through a
mechanism that relies on early induction and phosphory-
lation of c-Jun.20 Thus, the role of TGF-β1 in vessel
remodeling is still not well defined.
Apoptosis has been shown to be associated with a vari-
ety of physiologic and pathologic conditions in the car-
diovascular system. For instance, apoptosis has been
shown in postnatal heart morphogenesis,21 in postpartum
arterial remodeling, in the regulation of endothelial
turnover, and in pressure-overloaded hypertrophy.22-24
Apoptosis is modulated by variety of proapoptotic and
antiapoptotic factors. For example, Bcl-xS is a proapop-
totic factor, and increased induction of Bcl-xS expression
has been associated with SMC apoptosis in the intimal
thickening of balloon-injured carotid arteries.25 However,
antisense Bcl-x oligonucleotide induced apoptosis and
prevented arterial neointimal formation in murine cardiac
allografts.26 Thus, the specific role of apoptosis in vessel
remodeling remains poorly defined.
In the current study we aimed to test the hypothesis
that both apoptosis and cell proliferation are equally essen-
Arteries remodel in response to hemodynamic changes,
including hypertension.1-6 Hypertension not only induces
arterial remodeling but also promotes atherogenesis.7,8
Cell proliferation and apoptosis are thought to play an
important role in the balance of cellular and extracellular
volumes of the arterial wall during the remodeling.9-12
However, it has also been shown in hypertensive arteries
that smooth muscle cell (SMC) replication is increased
without counterbalance by increased apoptosis, which
results in medial thickening of arteries and arterioles.13
Many growth-modulating factors are involved in
remodeling. Transforming growth factor (TGF)–β1 is a
pleiotropic factor expressed within vascular cells that reg-
ulates cellularity in a tissue-specific manner. It can exert
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Objective: The molecular basis of vascular response to hypertension is largely unknown. Both cellular and extracellular
components are critical. In the current study we tested the hypothesis that there is a balance between vascular cell pro-
liferation and cell death during vessel remodeling in response to hypertension.
Methods: A midthoracic aortic coarctation was created in rats to induce an elevation of blood pressure proximal to the
coarctation. The time course was 1 and 3 days and 1, 2, and 4 weeks for the study of the proximal aorta. Ribonuclease
protection assay and Western blot analysis were used to evaluate gene expression of growth and apoptosis-related
cytokines with two sets of multiple probes, rCK-3 and rAPO-1. Cell proliferation was determined with BrdU (5-
bromo-2´-deoxyuridine) incorporation. Apoptosis was examined with TUNEL (transferase-mediated dUTP nick end-
labeling). Morphometry was performed on histologic sections.
Results: Coarctation produced hypertension in the proximal aorta, 118 ± 9 mm Hg versus 94 ± 6 mm Hg in controls
(P < .002). Both messenger RNA and protein levels of transforming growth factor (TGF)–β1 and TGF-β3 were
increased (P < .005 vs controls). Messenger RNA and protein of Bcl-xS and Fas ligand, known as proapoptotic factors,
were both reduced after coarctation (P < .005 vs controls). There was increased BrdU incorporation at 3 days and 1
and 2 weeks (P < .001 vs controls). There were no remarkable changes in the apoptosis rate until 4 weeks later.
Conclusion: Cell proliferation was stimulated at 3 days, and apoptosis was halted until 4 weeks. These changes were
associated with upregulation of TGF-β and downregulation of Bcl-xS and Fas ligand gene expression. These findings
suggest that a coordinated regulation of cell proliferation and cell death contributes to arterial remodeling in response
to acute sustained elevation of blood pressure. Cell proliferation precedes apoptosis by 2 weeks in this procedure. 
(J Vasc Surg 2001;33:570-8.)
tial in vessel remodeling, with an experimental acute
hypertension model. The results showed that the two
processes coexisted during aortic remodeling in response
to hypertension and that cell proliferation preceded apop-
tosis by 2 weeks.
MATERIALS AND METHODS
Aortic coarctation model. A midthoracic aortic
coarctation was created in rats (250-300 g). The proce-
dure was similar to our previous model in rabbits.5 The
study was approved by the Institutional Review Board,
and the animal care complied with the Guide for Care and
Use of Laboratory Animals (Institute of Laboratory
Animal Resources Commission of Life Science, National
Research Council. Washington: National Academy Press;
1996). Surgical procedures were conducted with the rats
under general anesthesia and in sterile conditions. Rats
were anesthetized with sodium pentobarbital (50 mg/kg)
intraperitoneally. After trachea intubation, the animals
were kept under the control of a respirator with a tidal vol-
ume of 2.5 mL at a frequency of 90 times per minute. Left
thoracotomy was performed at the fifth intercostal space
to expose the aorta, and a piece of surgical silk suture (#0)
was placed surrounding the midthoracic segment. A 20-
gauge needle with an outer diameter of 0.9 mm was
placed on the top of the aortic segment. The aorta and the
needle were tied together with the suture. The needle was
then retrieved immediately, leaving a 0.9-mm lumen
diameter at the constriction site. The chest was closed with
air suction. The tracheal tube was removed after the ani-
mal woke up. Before the rat was humanely killed, blood
pressure was measured through catheters introduced in
the carotid and femoral arteries. Sham-operated animals
were operated on in the same procedure as for the coarc-
tation except that the suture was positioned and tied up,
but there was no constriction of the aorta.
Time course. Acute aortic hypertension was induced
in a time course manner, 1 and 3 days and 1, 2, and 4
weeks (n = 3 each). An equal number of sham-operated
and age-matched animals served as controls. Two sets of
animals were used. One set was for the extraction of total
tissue RNA and protein and the other for perfusion fixa-
tion for frozen sections.
Sampling and perfusion fixation. For frozen tissue,
animals were intravenously injected with lethal doses of
pentobarbital. The aorta was dissected, and surrounding
fatty tissue was carefully removed. A 2-cm segment, 5 mm
proximal to the coarctation, was immediately taken and
frozen in liquid nitrogen for extraction of total tissue RNA
and proteins with Trizol Reagent (Life Technologies, Inc,
Rockville, Md). For histologic examination and detection
of cell proliferation and apoptosis, the animals were perfu-
sion fixed with 4% paraformaldehyde at room temperature
and at a pressure of 100 mm Hg for 30 minutes. The aorta
was then taken and further fixed in 4% paraformaldehyde.
A cross-sectional ring 5 mm proximal to the coarctation
was trimmed for frozen sections.
Ribonuclease protection assay. Gene expression of
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cell growth and apoptosis-related cytokines was studied in
the hypertensive aorta segment proximal to the coarcta-
tion. Ribonuclease protection assay (RPA) was performed
to obtain relative messenger RNA (mRNA) levels.
Nonradioactive RNA probes were transcribed with two
sets of multiple probe templates, rCK-3 and rAPO-1,
(Pharmingen, San Diego, Calif). An in vitro RNA tran-
scription kit (Promega, Madison, Wis) was applied with
the addition of biotin-16-UTP for labeling the probes
(Roche, Indianapolis, Ind). The sensitivity and specificity
of the probes were carefully tested before we started the
experiment. An RPA-III kit (Ambion, Austin, Tex) was
used for RPA following the manufacturer’s protocols. The
resulted films were scanned, and densitometry was per-
formed with NIH Image program version 1.62 (National
Institutes of Health, Bethesda, Md). The relative values of
protected probe fragments were expressed as a ratio of
their densitometry values over those of GAPDH (glycer-
aldehyde-3-phosphate dehydrogenase) in the same lane.
The mean and SD were calculated for each time point.
Cell proliferation assay. Incorporation techniques of
BrdU (5-bromo-2´-deoxyuridine) were used to assess
DNA synthesis for cell proliferation. Three injections of
BrdU (Sigma, St Louis, Mo), 50 mg/kg body weight,
were administered intraperitoneally to the animals 20, 
6, and 1 hours before they were humanely killed. Im-
munodetection of BrdU incorporation was performed on
frozen sections with a detection kit (Roche). The cell type
of BrdU-incorporated cells was assessed histologically. In
addition, an antibody against α-actin (Enzo Diagnostics,
Inc, Farmingdale, NY) was used to confirm SMCs in the
media. The number of BrdU-labeled nuclei was counted
from each whole cross section. The mean and SD were
obtained from three animals for each time interval, and
the cell proliferation rate was expressed as a number of
labeled nuclei per section.
Western blot analysis. Protein samples in 2× sodium
dodecylsulfate loading buffer were fractionated by 10%
sodium dodecylsulfate-polyacrylamide gel electrophoresis
at 100 V until the dye front reached the bottom of the gel.
The proteins were transferred onto 0.45-µm pore nitro-
cellulose membrane (Schleicher & Schuell, Keene, NH) at
40 V for 45 to 60 minutes. The membranes were blocked
with 5% nonfat milk and incubated at room temperature
for 1 hour with anti–TGF-β1 polyclonal antibody at a
1:200 dilution, anti–TGF-β3 polyclonal antibody at 
a 1:1000 dilution, anti–Bcl-xS/L polyclonal antibody at a
1:500 dilution, and anti–Fas ligand (FasL) polyclonal anti-
Mean aortic blood pressure (mm Hg)
Carotid Femoral
artery artery Gradient
Controls (n = 3) 94 ± 6 93 ± 5 0
Coarctated (n = 18) 118 ± 9* 98 ± 10 19 ± 8*
(range, 15-25)
*P < .002 compared with controls.
body at a 1:500 dilution (Santa Cruz Biotechnology, Inc,
Santa Cruz, Calif). After extensive washes with phosphate-
buffered saline, the blots were incubated with appropriate
secondary antibodies conjugated with horseradish peroxi-
dase (1:1000) for 1 hour at room temperature. The blots
were washed three times in phosphate-buffered saline, and
the protein complexes were detected with enhanced
chemiluminescence detection reagents according to the
manufacturer’s protocol (Amersham Pharmacia Biotech,
Inc, Piscataway, NJ). The data presented represent results
from three animals in each of the groups. Protein samples
from each animal were fractionated on more than one gel,
in duplicate or triplicate.
Apoptosis detection. The terminal deoxynucleotidyl
TUNEL (transferase-mediated dUTP nick end-labeling)
method was used on frozen sections to demonstrate apop-
tosis in SMCs and ECs. An in situ cell death detection kit
(Roche) was used for TUNEL with modifications. Nuclei
of apoptotic cells were thus labeled with fluorescein, and
the sections were counterstained with propidium iodide
and observed under laser-scanning confocal microscope
(Bio-Rad MRC 1024, Hercules, Calif). Negative controls
were included by omitting the labeling buffer. Positive
controls were obtained by digestion of the sections with
deoxyribonuclease I for 10 minutes at room temperature
before the detection procedure. Labeled nuclei were
counted per section. The mean and SD of each time point
were obtained from three animals for statistical analysis. In
addition, transmission electron microscopy (TEM) was
used to confirm the morphologic changes of apoptotic
cells. TEM sample preparation followed routine proce-
dures of our laboratories.3,4
Statistical analysis. Data were presented as mean ±
SD. Single factor analysis of variance and the Bonferroni
test were used for multiple comparisons. StatView soft-
ware version 5.0 (SAS Institute, Inc, San Francisco, Calif)
was used for the statistical analysis. The difference was
considered significant if P was less than .0033.
RESULTS
Blood pressure measurements. Midthoracic aortic
coarctation produced an elevation of blood pressure in the
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Fig 1. Left panels, top: Representative film resulted from an RPA procedure showing major bands, which correspond to TGF-β1 at the
256 base level and TGF-β3 at 226 base level as well as GAPDG at 97 base level according to manufacturer’s design. Far left lane shows
multiple probes without ribonuclease digestion. Far right lane shows molecular markers. Bottom: Relative mRNA levels of TGF-β1 and
β3. Data are expressed as density ratio of TGF-β over GAPDH from three separate experiments. TGF-β1 and TGF-β3 were highly
expressed with a peak at 1 day for each. The mRNA levels were declined after 1 day and returned to control levels by 2 weeks. *P <
.0033 compared with controls (Ctrl). Right panels, top: Representative bands of Western blot analysis for TGF-β1 and TGF-β3. Bottom:
Densitometry values show similar trend to mRNA levels for both TGF-β1 and β3. *P < .0030 compared with controls (Ctrl). Data are
means from three separate experiments. D, Day; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GM-CSF, granulocyte-
macrophage colony-stimulating factor; IFN, interferon; L32, ribosomal protein L32; mRNA, messenger RNA; TNF, tumor necrosis fac-
tor; W, week.
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proximal aorta (Table). There were blood pressure gradi-
ents across the coarctation, ranging from 15 to 25 mm Hg.
Gene expression of cell growth–related cytokines.
With the multiple probes of rCK-3, RPA revealed an
upregulation of TGF-β1 and TGF-β3 with an increase in
relative mRNA levels at 1 and 3 days (P < .0033 vs con-
trols) (Fig 1, left panels). TGF-β1 gene expression was
increased at 1 day and gradually declined thereafter, return-
ing to baseline levels at 2 weeks. TGF-β3 was highly
expressed at 1 and 3 days and returned to baseline levels at
2 weeks. Both TGF-β1 and TGF-β3 reached their expres-
sive peaks at 1 day with an increase of 1.9-fold and 2.3-
fold, respectively, compared with controls. Western blot
analysis revealed a similar trend for corresponding protein
expression. The protein levels of TGF-β1 and TGF-β3
increased significantly at 3 days (Fig 1, right panels).
Gene expression of apoptosis-related cytokines.
With the multiple-probe of rAPO-1, RPA showed that rel-
ative mRNA levels of Bcl-xS and FasL, known as proapop-
totic factors, were decreased at 1 day and remained. At 2
weeks Bcl-xS returned to control level, and at 4 weeks
FasL returned to higher than control level. The remark-
able change was that FasL expression rebounded to higher
than control level by 4 weeks (P < .0033 vs controls) (Fig
2, left panels). Western blot analysis showed a similar trend
for corresponding protein expression (Fig 2, right panels).
Cell proliferation was induced after coarctation.
Morphologic observation showed an increased cellularity,
including ECs and SMCs (Fig 3). The cells in the media were
SMCs as confirmed by staining with the antibody against
muscle α-actin (data not shown). BrdU-incorporated nuclei
were observed in the media, along the endothelial line and
in the adventitia (Fig 4). The incorporation rate was
increased at 3 days and at 1 and 2 weeks (P < .001 vs con-
trols) (Fig 5).
Cell apoptosis rate was increased by 4 weeks.
Apoptosis of vascular cells was detected with the TUNEL
method in all animals (Fig 6). Although the apoptosis rate
for the coarctated animals was not remarkably different in
the early 2-week period as compared with controls, there
was an increased apoptosis rate by 4 weeks (P < .0033
compared with controls, Figs 6 and 7). Ultrastructural
study with TEM confirmed characteristic features of apop-
totic cells. In general, the nuclei appeared to be condensed
Fig 2. Left panels, top: Representative film resulted from RPA procedure showing major bands, which correspond to Bcl-xS at 325 base
level and FasL at 286 base level as well as GAPDG at 97 base level according to manufacturer’s design. Far left lane shows multiple
probes without ribonuclease digestion. Far right lane shows molecular markers. Bottom: Relative mRNA levels of Bcl-xS and FasL. Data
are expressed as density ratio over GAPDH from three separate experiments. Bcl-xS and FasL were decreased immediately after coarc-
tation and remained so until 2 weeks when Bcl-xS returned to control level and 4 weeks, when FasL returned to higher than control
level. The remarkable change is that FasL was highly expressed after 2 weeks. *P < .0033 compared with controls (Ctrl). Right panels,
top: Representative bands of Western blot analysis for Bcl-xS and FasL. Bottom: Densitometry values show similar trend to mRNA levels
for Bcl-xS and FasL. *P < .0030 compared with controls (Ctrl). Data are means from three separate experiments. Bax, bel-2 associated
χ protein; Caspase, aspartate-specific cysteine proteinase; D, day; FasL, Fas ligand; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
L32, ribosomol protein L32; W, week.
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Fig 3. Cellularity of ECs and SMCs was within normal population (Ctrl). Starting from 1 day, cellularity of ECs and SMCs increased,
and they appeared crowded (1D-4W). Ctrl, Controls; D, day; W, week.
Fig 4. BrdU-incorporated nuclei were labeled dark blue by the immunodetection mediated by alkaline phosphatase. All nuclei were
counterstained pink with fast red. ECs and SMCs showed BrdU incorporation. Higher power view of the framed zone on 1-W panel is
shown on far right side. Ctrl, Control; D, day; W, week.
and fragmented, and finally, the cytoplasm became con-
densed, too (data not shown).
Lumen diameter and wall thickness. Morphometry
on histologic sections showed no statistically significant
difference in lumen diameter. However, wall thickness was
increased by 1 week (0.104 ± 0.001 mm vs 0.075 ± 0.001
mm for controls), and such thickness was maintained at 2
and 4 weeks (Fig 8).
DISCUSSION
This study showed that both cell proliferation and
apoptosis were involved in vessel remodeling in response
to acute elevation of blood pressure. Cellular proliferation
included increase in cellularity of both SMCs and ECs.
BrdU incorporation analysis demonstrated that the prolif-
eration rate peaked at 1 week after coarctation, suggesting
that the response was characterized by cell proliferation.
Along with the cellular proliferation, TGF-β1 and TGF-β3
gene expression was upregulated. The relative mRNA lev-
els for the two cytokines were increased as early as 1 day
and remained high at 3 days before returning to control
levels by 2 weeks. Changes of corresponding protein lev-
els had a similar trend. It seems that TGF-β gene upregu-
lation was an immediate response followed by cell
proliferation. Our results support the role of TGF-β1 and
TGF-β3 in cell proliferation.
Apoptosis was detected with TUNEL in all animals,
and ultrastructural features of apoptotic cells were con-
firmed with TEM. The apoptosis rate was not significantly
increased until 4 weeks after coarctation. This finding was
associated with an initial decrease in mRNA and in protein
levels of the proapoptosis genes, Bcl-xS and FasL, and a
rebound of them by 4 weeks. The mechanism that down-
regulation of Bcl-xS and FasL gene expression was not
associated with a decline in the apoptosis rate during the
early 2 weeks remains to be clarified. However, by 4
weeks, the gene expression for Bcl-xS returned to control
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level and rebounded to higher than control level for FasL,
which was attested by the increase in apoptosis rate at 4
weeks. These results showed that cell proliferation pre-
ceded apoptosis during the vessel remodeling in response
to high blood pressure.
Cell proliferation has been documented in vessel
remodeling in response to hypertension. The genes of the
TGF-β family play multiple roles in vessel remodeling in
response to hemodynamic changes. We have shown that
TGF-β1 gene expression was increased at 7 days after
flow-induced artery dilation.27 TGF-β may play a role in
modulating cell proliferation and gene expression of extra-
cellular matrix. In the current study we have observed the
increased BrdU incorporation across the wall. We have
previously demonstrated that gene expression of collagen
types I and III was increased.5 It is therefore speculated
that hypertension may upregulate the TGF-β gene expres-
sion, which modulates cell proliferation and gene expres-
sion of collagen. The outcome of these regulations may be
to maintain the strength of the vessel wall to limit its
enlargement.
Apoptosis is involved in tissue morphogenesis and
homeostasis. It is the essential counterpart of cell replica-
tion.28,29 It is postulated that remodeling during athero-
genesis or remodeling in hypertension might be mediated
by coordinated action of cell proliferation and apoptotic
cell death.30 Indeed, hypertension can induce marked
apoptosis in the vessel media and in target organs of
hypertension.31 Little is known about how apoptosis coor-
dinates with cell proliferation during the remodeling 
in response to hypertension. Our findings demonstrated
that the apoptosis rate increased at 4 weeks after the eleva-
tion of blood pressure, whereas cell proliferation reaction
started as early as 3 days and peaked at 1 week. This time
differentiation suggests that cell proliferation is the imme-
diate response to hypertension to ensure a reinforced vessel
wall, which may prevent the vessel wall from weakening.
Fig 5. BrdU incorporation rate (mean ± SD) was expressed as number of labeled nuclei of ECs and SMCs per section obtained from
three animals of each time interval. Incorporation rate increased at 3 days (52 ± 11) after coarctation. It peaked at 1 week (73 ± 7),
dropped to 31 ± 4 at 2 weeks, and returned to control level by 4 weeks (4 ± 1). *P < .001 compared with controls (4 ± 2).
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Fig 6. Cell apoptosis detection with TUNEL. Sections were observed under a laser-scanning confocal microscope. All nuclei were coun-
terstained red with propidium iodide, and nuclei of apoptotic cells were labeled green with fluorescein. ECs and SMCs showed positive
labeling. Elastic lamellae appeared light green because of their auto fluorescence. By 4 weeks, number of labeled nuclei seemed to be
increased. Ctrl, Control; D, day; NC, negative control; PC, positive control; W, week.
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Nevertheless, apoptosis would further help remodeling.
Although the increase in the apoptosis rate seemed to be
associated with the increase in wall thickness at 4 weeks
of coarctation, the actual contributor to the increased
wall thickness was the accumulation and remodeling of
newly synthesized collagens5 and other extracellular
matrix. Apoptosis is a cytokine-regulated form of cell
death. The expression and cascade activation of proteins
and proteinases appear as key events mediating apoptosis.
For instance, the protein Bcl-2 is expressed in SMCs.32
Constitutive expression of Bcl-2 suppresses apoptosis
almost universally with regard to the cell types.33 On the
other hand, the Bcl-2–related gene, Bcl-x, encodes both
positive and negative regulators of apoptosis depending
on alternative mRNA splicing.34 Bcl-xS is a proapoptosis
protein.35 We showed that Bcl-xS gene expression
returned to control levels at 4 weeks after reduction dur-
ing the earlier weeks. It has been demonstrated that both
ECs and vascular SMCs express Fas (CD95) (a member
of the tumor necrosis factor family of receptors), and
ECs also express FasL, suggesting that Fas-mediated
apoptosis of vascular SMCs may also occur. Indeed, mice
lacking components of the Fas/FasL signaling complex
have arteritis.36 In our study, FasL gene expression
showed a similar pattern to Bcl-xS, and moreover, the
gene expression of FasL was higher than that of controls
by 4 weeks, indicating that FasL may play a more trig-
gering role in the apoptosis event. It may not just be 
a coincidence that the apoptosis rate was increased by 
4 weeks.
Fig 7. Apoptosis rate (mean ± SD) was expressed as number of TUNEL positive nuclei per section obtained from three animals of each
interval. Apoptosis rate was not remarkably changed until 4 weeks (25 ± 6). *P < .0033 compared with controls (10 ± 6). D, Day; W, week.
Fig 8. Wall thickness was increased by 1 week, and such thickness was maintained at 2 and 4 weeks. *P < .002 as compared with age-
matched controls. D, Day; W, week.
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